Qatar's spending will remain ‘elevated’ in the healthcare sector given the country's substantial reserves, a new study has claimed.
The Gulf state is expected to spend $5.2bn (QAR19bn) on healthcare this year, compared to $4.7bn (QAR17.5bn) in 2014.
BMI Research said Qatar's healthcare sector will experience strong growth over its forecast period on the back of sizeable expansion projects in the country.
The healthcare market will continue to grow in Qatar as private sector engagement grows, coupled with increasing health insurance coverage.
In Qatar's pharmaceutical sector, BMI Research projects an expenditure of $582m (QAR2.12bn), this year compared with $521.7m (QAR1.9bn) in 2014.
According to BMI's Pharmaceutical Risk/Reward Index for the MEA matrix in Q3 2015, Qatar has retained its position in the MEA matrix of fourth place, with its score increasing to 55.5 out of 100 this quarter.
According to earlier reports, BMI Research said the leading private hospitals in Qatar had urged authorities concerned to review the entire system for importing drugs and allow them to import several life-saving medicines directly.
The development comes owing to an increase in the number of patients at private clinics and hospitals with the implementation of the national health insurance scheme.